Navigation Links
Study of planarians offers insight into germ cell development

The planarian is not as well known as other, more widely used subjects of scientific study ?model creatures such as the fruit fly, nematode or mouse. But University of Illinois cell and developmental biology professor Phillip Newmark thinks it should be. As it turns out, the tiny, seemingly cross-eyed flatworm is an ideal subject for the study of germ cells, precursors of eggs and sperm in all sexually reproducing species.

The planarian Newmark studies, Schmidtea mediterranea, is a tiny creature with a lot of interesting traits. Cut it in two (lengthwise or crosswise) and each piece will regenerate a new planarian, complete with brains, guts and ?in most cases ?gonads. Even when the planarian’s brain is severed from its body, it can regenerate all that is removed, including the reproductive organs.

In a new study published this month in the Proceedings of the National Academy of Sciences, Newmark and his colleagues at the U. of I. report that planarians share some important characteristics with mammals that may help scientists tease out the mechanisms by which germ cells are formed and maintained. Newmark’s team made a few discoveries related to a gene, called nanos, which was previously known to play a critical role in germ cell development in several other model organisms.

Unlike fruit flies and nematodes, which show signs of germ cell initiation in the earliest stages of their embryonic development, planarians do not generally express nanos or produce germ cells until several days after hatching. This delayed initiation of germ cell growth is called inductive specification, and is common to mammals and a number of other animals.

Graduate student Yuying Wang and the other team members were able to show that nanos is essential for inductive specification in planarians. Blocking nanos expression by means of RNA interference immediately after the planarians hatched prevented the emergence and development of germ cells. Blocking
'"/>

Source:University of Illinois at Urbana-Champaign


Page: 1 2

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
3. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
4. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
5. Study Links Ebola Outbreaks To Animal Carcasses
6. Breakthrough Microarray-based Technology for the Study of Cancer
7. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
8. Study finds more than one-third of human genome regulated by RNA
9. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
10. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
11. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works

Post Your Comments:
(Date:11/22/2009)...have succeeded in producing the polymers used for ...han through the use of fossil fuel based chemicals...w for the production of environmentally conscious ...l Biotechnology and Bioengineering to mark the j...ules found in everyday life in the form of plastic...
(Date:11/22/2009)...terfly,s proboscis looks like a straw -- long, sle...ke a paper towel, according to Konstantin Kornev o...s of this piece of insect anatomy to make small pr... Kornev will present his work next week at the 62...,s (APS) Division of Fluid Dynamics will take plac...
(Date:11/21/2009)...ewswire / - KINAXO Biotechnologies GmbH announce... new investors in the company, Leifina and Conmit ... Schumacher has been elected as a new member of th... Axel Ullrich, Hellmut Kirchner, Manfred Ferber as...tain Partners, BioM, High-Tech Grnderfonds, the Ma...
Breaking Biology News(10 mins):Bioengineers succeed in producing plastic without the use of fossil fuels 2KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3WHO Withdraws Notice of Concern for Mylans Matrix Unit 13730 1NTU and Temasek Foundation transfer technology knowhow to Chinas quake prone regions 9723 1NTU and Temasek Foundation transfer technology knowhow to Chinas quake prone regions 9723 2NTU and Temasek Foundation transfer technology knowhow to Chinas quake prone regions 9723 3Kristi Yamaguchi Olympic Ice Skater Pushes Seasonal Flu Shots 55601 1Kristi Yamaguchi Olympic Ice Skater Pushes Seasonal Flu Shots 55601 2Kristi Yamaguchi Olympic Ice Skater Pushes Seasonal Flu Shots 55601 3
...DGE, Mass.-MIT scientists have found a way to indu...t could one day serve as tiny engineered blood ves...ol the cells, development by growing them on a sur...rk was posted this month in an online issue of Adv...d one day be transplanted into tissues such as the...
...ON, Ill. --- Neurotransmitters have consequences. ...y life, giving us the ability to move, to talk, to...ters are getting it right and sending proper signa...lls. , Now a Northwestern University study repor...controls a neurotransmitter in the nematode C. ele...
...ILLE, Tenn. U.S. Courts have decreed that the fe...naging nuclear wastes that will ensure the safety ...s, a period that is 200 times the length of record...rtainty in Long-Term Planning Nuclear Waste Manag...om government, industry, academia and the environm...
Other Biology News:MIT works toward engineered blood vessels 2Overexcited neurons not good for cell health 2Overexcited neurons not good for cell health 3Managing nuclear wastes for the millennia 2
(Date:11/20/2009)...swire-FirstCall/ -- Dendreon Corporation (Nasdaq: ...g Administration (FDA) provided written acknowledg... Application (BLA) for PROVENGE® (sipuleucel-... Prescription Drug User Fee Act (PDUFA) date of Ma...on,s amended BLA. Dendreon is seeking licensure f...
(Date:11/20/2009)...OLEDO recently announced that a free webinar, &ldq...t-Line Particle Characterization”, will be p...e application of in situ particle characterization...ize a series of roller compaction runs while varyi...n forces. , (PRWEB) Novem...
(Date:11/19/2009)...wire-FirstCall/ -- Omeros Corporation (Nasdaq: OM...or the third quarter ended September 30, 2009. For... reported a net loss of $3.9 million, or $1.34 per... or $2.54 per share, for the same period in 2008. ...Company reported a net loss of $15.5 million, or $...
(Date:11/19/2009)...PRNewswire-FirstCall/ -- Spherix Incorporated (Nas...abetes therapy, and a provider of technical and re...biotechnology and pharmaceutical companies, today ...of Shareholders. ,, At the meeting, shareholder... the following members to the Board of Directors: ...
Breaking Biology Technology:Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Roller Compaction Process Optimization Using At-Line Particle Characterization 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4
...uly 1 BioMarin,Pharmaceutical Inc. (Nasdaq and SW...h.D., Chief Medical Officer of BioMarin, will pres... Conference in New York City on,Wednesday, July 9,...cess a live audio webcast of the presentation,via ...p://www.BMRN.com . A,replay of the presentation wi...
... Ben Eynon Each Assume Vice President Roles at ...N, Texas, July 1 Molecular Imprints, Inc., the,ma...ms and solutions, today,announced that Ben Eynon a...These distinguished industry veterans are assuming...ness development for semiconductors, and,vice pres...
...lized Psychiatric Patient Evaluation for Clinical ...ug Development, HAMILTON, N.J., July 1 MedAvante...ent evaluation, announced today that it has,closed...nd Trevi Health,Ventures. MedAvante has developed ... the assessment of patients undergoing treatment i...
Other Biology Technology:BioMarin to Present at the Collins Stewart Growth Conference 2Industry Veterans Join Molecular Imprints' Management Team 2Industry Veterans Join Molecular Imprints' Management Team 3MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures 2MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures 3MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures 4
VACUGENE PUMP 110V from GE Healthcare, formerly Amersham Biosciences
Rabbit Anti-DLK1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Cryopreservation Service from AbD Serotec
...mismatch repair minus strains of E. coli. Use of t...zed unmethylated strand (1), leading to high mutat...ystems as the GeneEditor and Altered Sites II Muta...e recA+, therefore inserts containing highly repet...
Biology Products: